Add to ORKGTargeted drugs against key pathogenetic molecules such as TNF-alpha have significantly improved outcomes in rheumatoid arthritis (RA). They are widely used in clinical practice and drug registries give us information to support their use. Adalimumab (ADA) is able to induce a comprehensive disease control in RA by achieving clinical, functional and radiographic control
Rheumatoid arthritis patients have been treated with disease modifying anti-rheumatic drugs (DMARDs)...
Objective. To assess the efficacy and safety of the fully human recombinant monoclonal anti-TNF anti...
To compare the effectiveness of tocilizumab (TCZ) and tumour necrosis factor (TNF) inhibitors (TNFi)...
Objective Targeted drugs against key pathogenetic molecules such as TNF-alpha have significantly imp...
OBJECTIVES: Targeted drugs against key pathogenetic molecules such as TNF-alpha have significantly i...
Clinical trials have shown that anti-tumour necrosis factor (TNF)-α drugs are effective in patients ...
Objective: To evaluate the safety and effectiveness of adalimumab alone or in combination with stand...
Objectives: Current guidelines rank abatacept, rituximab, tocilizumab and TNF-inhibitors (TNFi) as h...
Giuseppe Murdaca, Francesca Spanò, Francesco PuppoDepartment of Internal Medicine, Clinical I...
Background: Anti-Tumor Necrosis Factor alpha (anti-TNF) drugs markedly improved the therapeutic appr...
AbstractSince the discovery of the role of tumor necrosis factor in the physiopathological process o...
To compare treatment effectiveness in rheumatoid arthritis (RA) patients naïve to biological disease...
<div><p>Rheumatoid arthritis patients have been treated with disease modifying anti-rheumatic drugs ...
Abstract Background This double-blind, randomized, 78-week study evaluated the efficacy, safety, imm...
It has been found that tumour necrosis factor(TNF)-alpha plays a pivotal role in the pathogenesis of...
Rheumatoid arthritis patients have been treated with disease modifying anti-rheumatic drugs (DMARDs)...
Objective. To assess the efficacy and safety of the fully human recombinant monoclonal anti-TNF anti...
To compare the effectiveness of tocilizumab (TCZ) and tumour necrosis factor (TNF) inhibitors (TNFi)...
Objective Targeted drugs against key pathogenetic molecules such as TNF-alpha have significantly imp...
OBJECTIVES: Targeted drugs against key pathogenetic molecules such as TNF-alpha have significantly i...
Clinical trials have shown that anti-tumour necrosis factor (TNF)-α drugs are effective in patients ...
Objective: To evaluate the safety and effectiveness of adalimumab alone or in combination with stand...
Objectives: Current guidelines rank abatacept, rituximab, tocilizumab and TNF-inhibitors (TNFi) as h...
Giuseppe Murdaca, Francesca Spanò, Francesco PuppoDepartment of Internal Medicine, Clinical I...
Background: Anti-Tumor Necrosis Factor alpha (anti-TNF) drugs markedly improved the therapeutic appr...
AbstractSince the discovery of the role of tumor necrosis factor in the physiopathological process o...
To compare treatment effectiveness in rheumatoid arthritis (RA) patients naïve to biological disease...
<div><p>Rheumatoid arthritis patients have been treated with disease modifying anti-rheumatic drugs ...
Abstract Background This double-blind, randomized, 78-week study evaluated the efficacy, safety, imm...
It has been found that tumour necrosis factor(TNF)-alpha plays a pivotal role in the pathogenesis of...
Rheumatoid arthritis patients have been treated with disease modifying anti-rheumatic drugs (DMARDs)...
Objective. To assess the efficacy and safety of the fully human recombinant monoclonal anti-TNF anti...
To compare the effectiveness of tocilizumab (TCZ) and tumour necrosis factor (TNF) inhibitors (TNFi)...